Literature DB >> 26979265

An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots, Freckling, and Neurofibromas. An Update. Part I. Dermatological Clinical Criteria Diagnostic of the Disease.

A Hernández-Martín1, A Duat-Rodríguez2.   

Abstract

Neurofibromatosis type 1 (NF1) is the most common neurocutaneous syndrome and probably the one best known to dermatologists, who are generally the first physicians to suspect its diagnosis. Although the genetic locus of NF1 was identified on chromosome 17 in 1987, diagnosis of the disease is still mainly based on clinical observations and the diagnostic criteria of the National Institute of Health, dating from 1988. Cutaneous manifestations are particularly important because café-au-lait spots, freckling on flexural areas, and cutaneous neurofibromas comprise 3 of the 7 clinical diagnostic criteria. However, café-au-lait spots and freckling can also be present in other diseases. These manifestations are therefore not pathognomonic and are insufficient for definitive diagnosis in the early years of life. NF1 is a multisystemic disease associated with a predisposition to cancer. A multidisciplinary follow-up is necessary and dermatologists play an important role.
Copyright © 2016 AEDV. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Albinism; Cafe-au-lait spots; Efélides; Ephelids; Freckling; LEOPARD syndrome; Legius syndrome; Mancha café con leche; Neurofibroma; Neurofibromatosis tipo 1; Neurofibromatosis type 1; Neurofibromin; Neurofibromina; Pecas; Piebaldismo; RASopathies; Rasopatías; Síndrome LEOPARD; Síndrome de Legius

Mesh:

Year:  2016        PMID: 26979265     DOI: 10.1016/j.ad.2016.01.004

Source DB:  PubMed          Journal:  Actas Dermosifiliogr        ISSN: 0001-7310


  9 in total

1.  Diffuse Type Neurofibroma of the Forearm.

Authors:  Salim Al Lahham; Ghanem Aljassem; Rand Y Omari; Zaki Alyazji; Ruba Sada; Ayman Asnaf; Mutaz Abuelgasim
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-05-23

Review 2.  Familial Cancers of Head and Neck Region.

Authors:  Reshma Venugopal; Radhika Manoj Bavle; Paremala Konda; Sudhakara Muniswamappa; Soumya Makarla
Journal:  J Clin Diagn Res       Date:  2017-06-01

3.  Epidemiological profile and clinical characteristics of 491 Brazilian patients with neurofibromatosis type 1.

Authors:  Luiz Guilherme Darrigo Junior; Victor Evangelista de Faria Ferraz; Marina Candido Visontai Cormedi; Luissa Hikari Hayashi Araujo; Mariana Prado Silva Magalhães; Rafaella Curis Carneiro; Luis Henrique Nunes Sales; Mendel Suchmacher; Karin Soares Cunha; Aguinaldo Bonalumi Filho; David Rubem Azulay; Mauro Geller
Journal:  Brain Behav       Date:  2022-05-04       Impact factor: 3.405

4.  Decayed, missing, and restored teeth in patients with Neurofibromatosis Type 1.

Authors:  Reinhard E Friedrich; Anika Reul
Journal:  J Clin Exp Dent       Date:  2018-02-01

5.  Treatment of Café-Au-Lait Spots Using Q-Switched Alexandrite Laser: Analysis of Clinical Characteristics of 471 Children in Mainland China.

Authors:  Bin Zhang; Yan Chu; Zigang Xu; Yujuan Sun; Li Li; Xiaofeng Han; Chen Wang; Li Wei; Yuanxiang Liu; Lin Ma
Journal:  Lasers Surg Med       Date:  2019-05-25       Impact factor: 4.025

6.  Determination of Vitamin D Levels in Patients With Neurofibromatosis Type 1 in the Pediatric Age Group.

Authors:  Alessandra Santos; Mauro Geller; Spyros Mezitis; Allan E Rubenstein; Lisa Oliveira; Daniel Jm Medeiros Lima; Mendel Suchmacher Neto; Rafael Nigri; Karin Gonçalves Soares Cunha; Sanyu Takirambudde; Marcia Gonçalves Ribeiro
Journal:  Clin Pathol       Date:  2020-10-19

Review 7.  Imaging More than Skin-Deep: Radiologic and Dermatologic Presentations of Systemic Disorders.

Authors:  Mehrzad Shafiei; Firoozeh Shomal Zadeh; Bahar Mansoori; Hunter Pyle; Nnenna Agim; Jorge Hinojosa; Arturo Dominguez; Cristina Thomas; Majid Chalian
Journal:  Diagnostics (Basel)       Date:  2022-08-19

8.  Skin lesions in neurofibromatosis type 2: diagnostic and prognostic significance of cutaneous (plexiform) schwannomas.

Authors:  A Plana-Pla; B García; M Munera-Campos; N Catasus; E Serra Arenas; I Blanco; E Castellanos Perez; I Bielsa
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-05-21       Impact factor: 9.228

9.  Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1.

Authors:  Giovanni Corsello; Vincenzo Antona; Gregorio Serra; Federico Zara; Clara Giambrone; Luca Lagalla; Maria Piccione; Ettore Piro
Journal:  Ital J Pediatr       Date:  2018-04-04       Impact factor: 2.638

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.